TWO businesses based in The Biosphere on Newcastle Helix have been awarded funding to accelerate their innovations to support the global fight against the COVID-19.
Innovate UK, the UK’s innovation agency has awarded ExplantLab and Atelerix almost £50,000 each to fast track their ideas and research. Both are based in The Biosphere and were among only 800 applicants chosen to receive a share of £40million government investment out of a record 8,600 applications from across the UK.
Managed by Innovate UK, the Fast Start competition was launched in April to fast-track the development of…
Cambridge, UK, 2nd June 2020 / Following the retirement of Tony Brampton, Eddy Littler has been appointed as non-executive Chairman of Domainex Ltd.
Eddy began his research career at the University of Leeds obtaining his PhD in virology. After postdoctoral research at McMaster University in Canada, he joined the Paterson Institute for Cancer Research in Manchester. Eddy held senior positions with Wellcome Research Laboratories, GSK and Medivir, where he led the team that discovered Olysio which was a major drug for treatment of hepatitis C virus. Eddy became CEO of Domainex in May 2008 and…
Biocair, a global specialist in life sciences logistics, was selected to transport time-critical plasmids from the USA to the Africa Health Research Institute (AHRI) in Durban, South Africa.
AHRI Faculty Member and Research Group Leader at the Max Planck Institute for Infection Biology in Berlin, Dr Alex Sigal, highlighted the importance of the materials being transported and the standard of service provided by Biocair:
“These reagents that Biocair delivered to us from the USA, at record speed and surmounting considerable obstacles because of the lockdown both in the USA and in South Africa…
Dual-qualified solicitor and Chartered Trade Mark Attorney, Chris Hoole, last month relocated to the Cambridge office of leading intellectual property firm Appleyard Lees.
Chris is looking forward to supporting existing and new clients in Cambridge, the UK and beyond, from his new home base.
Chris will continue his work to help build the national litigation and trade mark practices of Appleyard Lees, as the firm positions itself for further growth in years to come.
“Chris is a fantastic lawyer who will be a great resource for clients in and around Cambridge,” said Robert Cumming, Head of…
Laupheim, Germany; Milford, MA, USA and Cambridge, UK, 19 May 2020: Rentschler Biopharma SE, a world-class contract development and manufacturing organization (CDMO) for biopharmaceuticals, and Horizon Discovery, a global leader in the application of gene editing and gene modulation for cell line engineering, today announced the signing of a commercial license agreement. Under the terms of the agreement, Horizon’s CHOSOURCE™ platform will be used in combination with Rentschler Biopharma’s novel in-house process for cell line development for difficult-to-express proteins. Horizon’s gene-edited…
We are excited to announce the launch of our new webinar series called BIODATAlks, taking the format of 30-45 minute interactive conversations, and hosted by the BioData Innovation Centre team at the Wellcome Genome Campus.
The webinars feature a variety of genomics and biodata experts- from established companies to start-ups and academic spinouts. These online sessions are designed to introduce you to thought-leaders, founders, and experts who have created successful teams and enterprises in the biodata and genomics fields. With absolutely no pre-recorded content, speakers expect to have…
AMSBIO reports on the positive customer feedback received for their One-Step Luciferase Assay kit recently introduced for quantitation of firefly luciferase activity in mammalian cell culture.Dr Maja Petkovic, Custom Services Business Unit Manager at AMSBIO said "Initial uptake of this new kit has been strong particularly for high throughput screening applications. Our customers have appreciated that the kit offers not just high sensitivity but also the convenience of a homogeneous, single step protocol. In a recent study, researchers at Excellerate Bioscience (https://excelleratebio.…
In recent months, the world has faced its most significant peace-time crisis, effecting all corners of the globe. Like many others, we at PIR International have adopted new working practices to adapt and to continue to support our clients and candidates, who are developing lifesaving treatments and technologies for all diseases. We wish to take this opportunity to thank those developing these important medicines, diagnostics and those on the frontline in healthcare settings looking after all those in need, effected by COVID-19, but also all other diseases which continue to impact millions of…
Westbury, NY – May 11, 2020 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it is adding high-purity Kupffer cells to its portfolio of human primary hepatic cells to support liver disease drug discovery and development and help predict adverse drug reactions.
Kupffer cells perform a scavenger role in the liver, removing small particles, senescent cells and cell debris. They also play an important role in the immune response to liver pathogens. Dysregulation of the Kupffer cell response contributes to chronic inflammation,…